Treatment of multiple myeloma in patients with Gaucher disease.
Machaczka
Maciej
M
Lerner
Richard
R
Klimkowska
Monika
M
Hägglund
Hans
H
D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D017809:Fatal Outcome; D005776:Gaucher Disease / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007136:Immunoglobulins / Q000097:blood; D015470:Leukemia, Myeloid, Acute / Q000209:etiology; D008297:Male; D008558:Melphalan / Q000008:administration & dosage / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000097:blood / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000150:complications / Q000188:drug therapy
D018906:Antineoplastic Agents, Alkylating; D007136:Immunoglobulins; C009823:M-proteins (Myeloma); D008558:Melphalan; D011241:Prednisone